comparemela.com

Latest Breaking News On - Capital allocation term trust company profile - Page 6 : comparemela.com

Insider Buying: BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) Major Shareholder Purchases 301,375 Shares of Stock

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT – Get Free Report) major shareholder Saba Capital Management, L.P. bought 301,375 shares of the company’s stock in a transaction on Monday, November 13th. The shares were acquired at an average price of $15.13 per share, for a total transaction of $4,559,803.75. Following the transaction, the insider now […]

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) Major Shareholder Saba Capital Management, L P Purchases 322,194 Shares

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT – Get Free Report) major shareholder Saba Capital Management, L.P. acquired 322,194 shares of BlackRock ESG Capital Allocation Term Trust stock in a transaction on Monday, October 16th. The shares were bought at an average cost of $14.79 per share, for a total transaction of $4,765,249.26. Following the […]

Short Interest in BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) Grows By 117 6%

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT – Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 38,300 shares, an increase of 117.6% from the August 31st total of 17,600 shares. Based on an average trading volume of 210,700 shares, […]

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) Major Shareholder Saba Capital Management, L P Acquires 74,372 Shares

BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT – Get Free Report) major shareholder Saba Capital Management, L.P. acquired 74,372 shares of the stock in a transaction that occurred on Monday, September 25th. The stock was purchased at an average cost of $14.78 per share, with a total value of $1,099,218.16. Following the completion of the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.